Latest news with #KRTL
Yahoo
4 days ago
- Business
- Yahoo
KRTL Holding Group Inc. Advances in 15c2-11 Process with Court-Approved Shareholder Verification Initiative
Lakewood, CO, June 04, 2025 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE KRTL Holding Group Inc. Advances in 15c2-11 Process with Court-Approved Shareholder Verification Initiative KRTL Holding Group Inc. (OTC: KRTL) announces a significant advancement in its journey toward full compliance with SEC Rule 15c2-11. Following a comprehensive review of legacy shareholder records predating KRTL's acquisition and restructuring, the company has successfully obtained a court order from the Third Judicial District Court, Salt Lake County, Utah. This order authorizes KRTL to initiate a structured, court-supervised verification and remediation process of legacy shareholders. Court-Approved Shareholder Verification Process Under the terms of the court order dated May 27, 2025, KRTL has commenced a rigorous program to: Send certified, court-approved notices to shareholders listed in historical records, requesting verifiable proof of ownership. Provide a 60-day window for shareholders to submit acceptable documentation, including government-issued identification and proof of stock ownership. Petition for the cancellation of shares tied to non-responsive or unverifiable shareholders through judicial declaration. Allow for discretionary reissuance in cases where late verification is provided, maintaining corporate governance standards. This proactive step is a major milestone in KRTL's efforts to cleanse its shareholder records of fictitious or unverified entries—a critical component to comply with SEC Rule 15c2-11 which governs the public quoting of OTC securities, and to facilitate Rule 144 resale eligibility, which requires a clear chain of ownership. What This Means for Our Shareholders and the Company For current and prospective shareholders, this initiative ensures a more transparent and trustworthy shareholder base. By removing legacy uncertainties, KRTL strengthens its corporate governance and enhances the integrity of its shareholder records, providing a strong foundation for future growth and regulatory standing. For KRTL, this action accelerates the company's compliance efforts with FINRA and SEC requirements, moving it significantly closer to achieving full Rule 15c2-11 compliance, a key milestone in reestablishing public market quotation and increasing shareholder value. Commitment to Transparency and Compliance 'This is a pivotal moment for KRTL Holding Group,' said Cesar Herrera, CEO of KRTL Holding Group Inc. 'We are taking decisive action to ensure the accuracy of our shareholder records and to align our operations with the highest standards of regulatory compliance. By resolving these legacy issues, we aim to restore confidence in our shareholder registry and pave the way toward improved trading access and long-term value creation.' About KRTL Holding Group Inc. KRTL Holding Group Inc. (OTC: KRTL) operates through its wholly owned subsidiaries, KRTL Biotech Inc. and KRTL International Corp. The Company leverages strategic synergies across industries to pursue investments, mergers, and partnerships that deliver shareholder value. Focused on biotech, technology, and emerging market opportunities, KRTL Holding Group is committed to growth, innovation, and operational excellence. Additional information on KRTL is available online at and and This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to differ materially from any future results, performance, or achievements expressed or implied by these forward-looking statements. Words such as "anticipates," "believes," "plans," "expects," "intends," "projects," "estimates," "future," and "opportunity" and similar expressions are used to identify these forward-looking statements. Forward-looking statements are not guarantees of future performance. These risks and uncertainties include, but are not limited to, changes in regulatory requirements, market conditions, and other factors described in the Company's filings. Additional information concerning risks and uncertainties that could materially affect KRTL's business and financial results is included in the Company's filings with the OTC Markets and, where applicable, the SEC. You should not place undue reliance on forward-looking statements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. CONTACT: info@ info@ info@ in to access your portfolio
Yahoo
09-04-2025
- Business
- Yahoo
KRTL Holding Announces Acquisition of Neurogen Brain Balancing, LLC – A Strategic Merger Accelerating Global Neurotech and Mental Wellness Expansion
Lakewood, CO, April 09, 2025 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE KRTL Holding Announces Acquisition of Neurogen Brain Balancing, LLC – A Strategic Merger Accelerating Global Neurotech and Mental Wellness Expansion KRTL Holding Group Inc., a diversified international enterprise focused on biotech innovation, regulatory infrastructure, and strategic investment, is pleased to announce the acquisition of Neurogen Brain Balancing, LLC, a California-based neurotechnology company known for its advanced brain balancing therapies and personalized cognitive optimization systems. This transformative acquisition expands KRTL's presence in the mental wellness space and enhances its position at the intersection of neuroscience, biotechnology, and global healthcare. This acquisition establishes Neurogen as a subsidiary of KRTL Holding Group Inc., representing a pivotal step in the company's broader strategy to integrate advanced neurotechnology into its ecosystem and support the growth of scalable mental health solutions. Under the terms of the transaction, KRTL has acquired 100% of Neurogen's equity through a stock-based structure that also includes a collaborative profit-sharing agreement. Additional elements of the consideration include KRTL's commitment to support Neurogen's entry into new markets and provide FDA-related services to enhance regulatory pathways and strategic growth alignment between the two companies. 'We are thrilled to welcome Neurogen into the KRTL Holding Group family,' said Cesar Herrera, CEO of KRTL Holding Group. 'In today's rapidly evolving global environment, diversification is not just a strategy—it's a necessity. By bringing Neurogen into our ecosystem, we strengthen our ability to remain agile, resilient, and forward-thinking across multiple sectors. Their innovative work is a natural fit for our mission to invest in businesses that shape the future.' Neurogen's proprietary neurotechnology utilizes advanced neuromodulation protocols that support applications ranging from cognitive performance enhancement to stress reduction and post-trauma recovery. The platform is particularly well-positioned to address critical gaps in the continuation of care for patients seeking alternative therapies. By offering non-opioid, non-invasive treatment options with simplified access, the technology aligns with broader healthcare priorities around expanding safe, effective, and accessible behavioral and neurological health interventions. "This acquisition marks an exciting new chapter for Neurogen. Joining forces with KRTL Holding Group enables us to accelerate our mission of transforming mental health treatment through cutting-edge neurotechnology. With KRTL's global infrastructure and regulatory expertise, we're well-positioned to scale our solutions and reach underserved communities worldwide. Together, we aim to expand access to non-invasive, personalized brain health therapies—advancing a new global standard for neurological wellness," said Gregory Gillispie, President of NeuroGen. "The guidance and infrastructure offered by KRTL enhance our ability to grow responsibly while continuing to focus on improving lives through brain balance." Strategic Integration and Global Expansion Framework As part of the integration, Neurogen is being incorporated into KRTL's operational and regulatory infrastructure. These efforts, which include brand alignment across digital channels and investor communications, financial system harmonization, and scalable operational planning, are underway and being informed by both internal leadership and third-party advisors. KRTL's internal systems, including its Quality Management System (QMS) and Enterprise Resource Planning (ERP) infrastructure, are currently under expert review. This assessment is aimed at identifying the most effective enhancements to support joint business capabilities and long-term performance. Further coordination is focused on regulatory and clinical alignment, including FDA-compliant trial design and support for international submissions. Neurogen is also positioned to participate in real-world data research through its connection with Centro de Investigaciones Químicas - CIQ S.R.L in Bolivia, contributing to global product validation efforts. As the collaboration evolves, KRTL intends to issue follow-up announcements that will provide added clarity, updates on integration progress, and forward-looking insights. About KRTL Holding Group Inc. KRTL Holding Group Inc. is a dynamic holding company operating through its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. These subsidiaries specialize in biopharmaceutical innovation, international trade, and compliance-driven healthcare advancements. By leveraging strategic mergers, acquisitions, and joint ventures, KRTL Holding Group continues to push the boundaries of scientific research, regulatory compliance, and global business solutions. Additional information on KRTL is available online at and and This press release contains forward-looking statements under the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, anticipated business developments, regulatory advancements, and strategic growth plans. Such forward-looking statements involve known and unknown risks that may cause actual results to differ materially from those expressed or implied. KRTL Holding Group assumes no obligation to update or revise forward-looking statements, except as required by law. Any updates will be made in accordance with applicable SEC regulations and disclosure obligations. Readers are cautioned not to place undue reliance on forward-looking statements. CONTACT: info@ info@ info@ in to access your portfolio
